Adenoviral vectors for in vivo gene delivery to oligodendrocytes : transgene expression and cytopathic consequences

Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (Adl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gene therapy 1999-08, Vol.6 (8), p.1360-1367
Hauptverfasser: FRANKLIN, R. J. M, QUICK, M. M, HAASE, G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1367
container_issue 8
container_start_page 1360
container_title Gene therapy
container_volume 6
creator FRANKLIN, R. J. M
QUICK, M. M
HAASE, G
description Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (AdlacZ) as a means of establishing the value of these vectors for gene delivery to oligodendrocytes in adult rat white matter. Our results indicate that although such an approach can be used to induce transgene expression in oligodendrocytes, it is complicated by both immunogenic and cytopathic effects. Thus, in normal animals, injection of DeltaE1/E3 adenoviral vectors was associated with a robust immune response that led to a lack of expression by 40 days after injection. In order to overcome this complication, virus was injected into the white matter of immuno-deficient athymic rats. These experiments indi- cated that even in the absence of a T cell response high viral titres of DeltaE1/E3 adenoviral vectors had a profound cytopathic effect leading to death of oligodendrocytes and hence demyelination. A similar cytopathic effect was demonstrated using an adenoviral vector expressing the neurocytokine ciliary neurotrophic factor (AdCNTF). As the titre of injected virus was decreased there was a significant decrease in the number of transgene expressing cells. These experiments therefore indicated that in immunodeficient recipients there is a narrow window of virus titre that results in a high rate of infectivity and expression without significant cytopathic consequences. At higher viral titres the cytopathic effects include oligodendrocyte death and demyelination, while at lower titres there is a significant decrease in the efficiency of the number of cells expressing the transgene.
doi_str_mv 10.1038/sj.gt.3300971
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70018419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2644612274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-57c139c240eed46a4b2f9d5b6517733b62c82cd76b9c1f43ba82953e9ecf3c593</originalsourceid><addsrcrecordid>eNqF0U1vEzEQBmALUdFQOHJFlkDcNvhr7TW3quKjUqVeytnyemeDo40dPM6q-fdsSSQQF05zeWZGMy8hbzhbcya7j7hdb-paSsas4c_Iiiujm1Zp8ZysmNW2MVx0l-Ql4pYxpkwnXpBLzpQ2UrMVwesBUp5j8ROdIdRckI650JjoHOdMN5CADjDFGcqR1kzzFDd56RlKDscKSD_RWnzC3xAe9wUQY07Up4EuIO99_REDDTkh_DxACoCvyMXoJ4TX53pFvn_5_HDzrbm7_3p7c33XBGlMbVoTuLRBKAYwKO1VL0Y7tL1uuTFS9lqEToTB6N4GPirZ-07YVoKFMMrQWnlFPpzm7kteVmN1u4gBpsknyAd0hjHeKf5_yI00kskn-O4fuM2HkpYjnNBKaS6EUYtqTiqUjFhgdPsSd74cHWfuKTSHW7ep7hza4t-epx76HQx_6VNKC3h_Bh6Dn8bl3yHiH2eV4qaVvwBjTaE1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2644612274</pqid></control><display><type>article</type><title>Adenoviral vectors for in vivo gene delivery to oligodendrocytes : transgene expression and cytopathic consequences</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Free E-Journal (出版社公開部分のみ)</source><creator>FRANKLIN, R. J. M ; QUICK, M. M ; HAASE, G</creator><creatorcontrib>FRANKLIN, R. J. M ; QUICK, M. M ; HAASE, G</creatorcontrib><description>Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (AdlacZ) as a means of establishing the value of these vectors for gene delivery to oligodendrocytes in adult rat white matter. Our results indicate that although such an approach can be used to induce transgene expression in oligodendrocytes, it is complicated by both immunogenic and cytopathic effects. Thus, in normal animals, injection of DeltaE1/E3 adenoviral vectors was associated with a robust immune response that led to a lack of expression by 40 days after injection. In order to overcome this complication, virus was injected into the white matter of immuno-deficient athymic rats. These experiments indi- cated that even in the absence of a T cell response high viral titres of DeltaE1/E3 adenoviral vectors had a profound cytopathic effect leading to death of oligodendrocytes and hence demyelination. A similar cytopathic effect was demonstrated using an adenoviral vector expressing the neurocytokine ciliary neurotrophic factor (AdCNTF). As the titre of injected virus was decreased there was a significant decrease in the number of transgene expressing cells. These experiments therefore indicated that in immunodeficient recipients there is a narrow window of virus titre that results in a high rate of infectivity and expression without significant cytopathic consequences. At higher viral titres the cytopathic effects include oligodendrocyte death and demyelination, while at lower titres there is a significant decrease in the efficiency of the number of cells expressing the transgene.</description><identifier>ISSN: 0969-7128</identifier><identifier>EISSN: 1476-5462</identifier><identifier>DOI: 10.1038/sj.gt.3300971</identifier><identifier>PMID: 10467360</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Adenoviridae - genetics ; Adenoviridae - immunology ; Adenovirus ; Animals ; Biological and medical sciences ; Biotechnology ; Ciliary neurotrophic factor ; Demyelinating Diseases - virology ; Demyelination ; Expression vectors ; Fundamental and applied biological sciences. Psychology ; Gene Expression - genetics ; Gene Expression - immunology ; Gene therapy ; Gene transfer ; Gene Transfer Techniques ; Genetic Vectors - genetics ; Health. Pharmaceutical industry ; Immunodeficiency ; Immunogenicity ; Industrial applications and implications. Economical aspects ; Infectivity ; Injection ; Lymphocytes T ; Oligodendrocytes ; Oligodendroglia - immunology ; Oligodendroglia - virology ; Rats ; Rats, Nude ; Rats, Sprague-Dawley ; Reporter gene ; Reverse Transcriptase Polymerase Chain Reaction - methods ; Spinal Cord - immunology ; Spinal Cord - virology ; Substantia alba ; Transgenes ; Transgenes - genetics ; Viruses</subject><ispartof>Gene therapy, 1999-08, Vol.6 (8), p.1360-1367</ispartof><rights>1999 INIST-CNRS</rights><rights>Macmillan Publishers Limited 1999.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-57c139c240eed46a4b2f9d5b6517733b62c82cd76b9c1f43ba82953e9ecf3c593</citedby><cites>FETCH-LOGICAL-c377t-57c139c240eed46a4b2f9d5b6517733b62c82cd76b9c1f43ba82953e9ecf3c593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1944175$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10467360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FRANKLIN, R. J. M</creatorcontrib><creatorcontrib>QUICK, M. M</creatorcontrib><creatorcontrib>HAASE, G</creatorcontrib><title>Adenoviral vectors for in vivo gene delivery to oligodendrocytes : transgene expression and cytopathic consequences</title><title>Gene therapy</title><addtitle>Gene Ther</addtitle><description>Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (AdlacZ) as a means of establishing the value of these vectors for gene delivery to oligodendrocytes in adult rat white matter. Our results indicate that although such an approach can be used to induce transgene expression in oligodendrocytes, it is complicated by both immunogenic and cytopathic effects. Thus, in normal animals, injection of DeltaE1/E3 adenoviral vectors was associated with a robust immune response that led to a lack of expression by 40 days after injection. In order to overcome this complication, virus was injected into the white matter of immuno-deficient athymic rats. These experiments indi- cated that even in the absence of a T cell response high viral titres of DeltaE1/E3 adenoviral vectors had a profound cytopathic effect leading to death of oligodendrocytes and hence demyelination. A similar cytopathic effect was demonstrated using an adenoviral vector expressing the neurocytokine ciliary neurotrophic factor (AdCNTF). As the titre of injected virus was decreased there was a significant decrease in the number of transgene expressing cells. These experiments therefore indicated that in immunodeficient recipients there is a narrow window of virus titre that results in a high rate of infectivity and expression without significant cytopathic consequences. At higher viral titres the cytopathic effects include oligodendrocyte death and demyelination, while at lower titres there is a significant decrease in the efficiency of the number of cells expressing the transgene.</description><subject>Adenoviridae - genetics</subject><subject>Adenoviridae - immunology</subject><subject>Adenovirus</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Ciliary neurotrophic factor</subject><subject>Demyelinating Diseases - virology</subject><subject>Demyelination</subject><subject>Expression vectors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression - genetics</subject><subject>Gene Expression - immunology</subject><subject>Gene therapy</subject><subject>Gene transfer</subject><subject>Gene Transfer Techniques</subject><subject>Genetic Vectors - genetics</subject><subject>Health. Pharmaceutical industry</subject><subject>Immunodeficiency</subject><subject>Immunogenicity</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Infectivity</subject><subject>Injection</subject><subject>Lymphocytes T</subject><subject>Oligodendrocytes</subject><subject>Oligodendroglia - immunology</subject><subject>Oligodendroglia - virology</subject><subject>Rats</subject><subject>Rats, Nude</subject><subject>Rats, Sprague-Dawley</subject><subject>Reporter gene</subject><subject>Reverse Transcriptase Polymerase Chain Reaction - methods</subject><subject>Spinal Cord - immunology</subject><subject>Spinal Cord - virology</subject><subject>Substantia alba</subject><subject>Transgenes</subject><subject>Transgenes - genetics</subject><subject>Viruses</subject><issn>0969-7128</issn><issn>1476-5462</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0U1vEzEQBmALUdFQOHJFlkDcNvhr7TW3quKjUqVeytnyemeDo40dPM6q-fdsSSQQF05zeWZGMy8hbzhbcya7j7hdb-paSsas4c_Iiiujm1Zp8ZysmNW2MVx0l-Ql4pYxpkwnXpBLzpQ2UrMVwesBUp5j8ROdIdRckI650JjoHOdMN5CADjDFGcqR1kzzFDd56RlKDscKSD_RWnzC3xAe9wUQY07Up4EuIO99_REDDTkh_DxACoCvyMXoJ4TX53pFvn_5_HDzrbm7_3p7c33XBGlMbVoTuLRBKAYwKO1VL0Y7tL1uuTFS9lqEToTB6N4GPirZ-07YVoKFMMrQWnlFPpzm7kteVmN1u4gBpsknyAd0hjHeKf5_yI00kskn-O4fuM2HkpYjnNBKaS6EUYtqTiqUjFhgdPsSd74cHWfuKTSHW7ep7hza4t-epx76HQx_6VNKC3h_Bh6Dn8bl3yHiH2eV4qaVvwBjTaE1</recordid><startdate>19990801</startdate><enddate>19990801</enddate><creator>FRANKLIN, R. J. M</creator><creator>QUICK, M. M</creator><creator>HAASE, G</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>19990801</creationdate><title>Adenoviral vectors for in vivo gene delivery to oligodendrocytes : transgene expression and cytopathic consequences</title><author>FRANKLIN, R. J. M ; QUICK, M. M ; HAASE, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-57c139c240eed46a4b2f9d5b6517733b62c82cd76b9c1f43ba82953e9ecf3c593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adenoviridae - genetics</topic><topic>Adenoviridae - immunology</topic><topic>Adenovirus</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Ciliary neurotrophic factor</topic><topic>Demyelinating Diseases - virology</topic><topic>Demyelination</topic><topic>Expression vectors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression - genetics</topic><topic>Gene Expression - immunology</topic><topic>Gene therapy</topic><topic>Gene transfer</topic><topic>Gene Transfer Techniques</topic><topic>Genetic Vectors - genetics</topic><topic>Health. Pharmaceutical industry</topic><topic>Immunodeficiency</topic><topic>Immunogenicity</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Infectivity</topic><topic>Injection</topic><topic>Lymphocytes T</topic><topic>Oligodendrocytes</topic><topic>Oligodendroglia - immunology</topic><topic>Oligodendroglia - virology</topic><topic>Rats</topic><topic>Rats, Nude</topic><topic>Rats, Sprague-Dawley</topic><topic>Reporter gene</topic><topic>Reverse Transcriptase Polymerase Chain Reaction - methods</topic><topic>Spinal Cord - immunology</topic><topic>Spinal Cord - virology</topic><topic>Substantia alba</topic><topic>Transgenes</topic><topic>Transgenes - genetics</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FRANKLIN, R. J. M</creatorcontrib><creatorcontrib>QUICK, M. M</creatorcontrib><creatorcontrib>HAASE, G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FRANKLIN, R. J. M</au><au>QUICK, M. M</au><au>HAASE, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adenoviral vectors for in vivo gene delivery to oligodendrocytes : transgene expression and cytopathic consequences</atitle><jtitle>Gene therapy</jtitle><addtitle>Gene Ther</addtitle><date>1999-08-01</date><risdate>1999</risdate><volume>6</volume><issue>8</issue><spage>1360</spage><epage>1367</epage><pages>1360-1367</pages><issn>0969-7128</issn><eissn>1476-5462</eissn><abstract>Replication defective viral vectors provide a potentially useful means of gene transfer to oligodendrocytes and thus for studying the pathogenesis of white matter disease. In this study we have examined the expression pattern of E1/E3 deleted adenoviral vectors expressing the reporter gene LacZ (AdlacZ) as a means of establishing the value of these vectors for gene delivery to oligodendrocytes in adult rat white matter. Our results indicate that although such an approach can be used to induce transgene expression in oligodendrocytes, it is complicated by both immunogenic and cytopathic effects. Thus, in normal animals, injection of DeltaE1/E3 adenoviral vectors was associated with a robust immune response that led to a lack of expression by 40 days after injection. In order to overcome this complication, virus was injected into the white matter of immuno-deficient athymic rats. These experiments indi- cated that even in the absence of a T cell response high viral titres of DeltaE1/E3 adenoviral vectors had a profound cytopathic effect leading to death of oligodendrocytes and hence demyelination. A similar cytopathic effect was demonstrated using an adenoviral vector expressing the neurocytokine ciliary neurotrophic factor (AdCNTF). As the titre of injected virus was decreased there was a significant decrease in the number of transgene expressing cells. These experiments therefore indicated that in immunodeficient recipients there is a narrow window of virus titre that results in a high rate of infectivity and expression without significant cytopathic consequences. At higher viral titres the cytopathic effects include oligodendrocyte death and demyelination, while at lower titres there is a significant decrease in the efficiency of the number of cells expressing the transgene.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>10467360</pmid><doi>10.1038/sj.gt.3300971</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0969-7128
ispartof Gene therapy, 1999-08, Vol.6 (8), p.1360-1367
issn 0969-7128
1476-5462
language eng
recordid cdi_proquest_miscellaneous_70018419
source MEDLINE; Springer Nature - Complete Springer Journals; Free E-Journal (出版社公開部分のみ)
subjects Adenoviridae - genetics
Adenoviridae - immunology
Adenovirus
Animals
Biological and medical sciences
Biotechnology
Ciliary neurotrophic factor
Demyelinating Diseases - virology
Demyelination
Expression vectors
Fundamental and applied biological sciences. Psychology
Gene Expression - genetics
Gene Expression - immunology
Gene therapy
Gene transfer
Gene Transfer Techniques
Genetic Vectors - genetics
Health. Pharmaceutical industry
Immunodeficiency
Immunogenicity
Industrial applications and implications. Economical aspects
Infectivity
Injection
Lymphocytes T
Oligodendrocytes
Oligodendroglia - immunology
Oligodendroglia - virology
Rats
Rats, Nude
Rats, Sprague-Dawley
Reporter gene
Reverse Transcriptase Polymerase Chain Reaction - methods
Spinal Cord - immunology
Spinal Cord - virology
Substantia alba
Transgenes
Transgenes - genetics
Viruses
title Adenoviral vectors for in vivo gene delivery to oligodendrocytes : transgene expression and cytopathic consequences
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T14%3A12%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adenoviral%20vectors%20for%20in%20vivo%20gene%20delivery%20to%20oligodendrocytes%20:%20transgene%20expression%20and%20cytopathic%20consequences&rft.jtitle=Gene%20therapy&rft.au=FRANKLIN,%20R.%20J.%20M&rft.date=1999-08-01&rft.volume=6&rft.issue=8&rft.spage=1360&rft.epage=1367&rft.pages=1360-1367&rft.issn=0969-7128&rft.eissn=1476-5462&rft_id=info:doi/10.1038/sj.gt.3300971&rft_dat=%3Cproquest_cross%3E2644612274%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2644612274&rft_id=info:pmid/10467360&rfr_iscdi=true